High Fat Diet Mediates Amyloid-β Cleaving Enzyme 1 Phosphorylation and SUMOylation, Enhancing Cognitive Impairment in APP/PS1 Mice.

BACKGROUND Alzheimer's disease (AD) is the most common form of dementia in older adults and extracellular accumulation of amyloid-β (Aβ) is one of the two characterized pathologies of AD. Obesity is significantly associated with AD developing factors. Several studies have reported that high fat diet (HFD) influenced Aβ accumulation and cognitive performance during AD pathology. However, the underlying neurobiological mechanisms have not yet been elucidated. OBJECTIVE The objective of this study was to explore the underlying neurobiological mechanisms of HFD influenced Aβ accumulation and cognitive performance during AD pathology. METHODS 2.5-month-old male APP/PS1 mice were randomly separated into two groups: 1) the normal diet (ND) group, fed a standard diet (10 kcal%fat); and 2) the HFD group, fed a high fat diet (40 kcal%fat, D12492; Research Diets). After 4 months of HFD or ND feeding, mice in the two groups were subjected for further ethological, morphological, and biochemical analyses. RESULTS A long-term HFD diet significantly increased perirenal fat and impaired dendritic integrity and aggravated neurodegeneration, and augmented learning and memory deficits in APP/PS1 mice. Furthermore, the HFD increased beta amyloid cleaving enzyme 1 (BACE1) dephosphorylation and SUMOylation, resulting in enhanced enzyme activity and stability, which exacerbated the deposition of amyloid plaques. CONCLUSION Our study demonstrates that long-term HFD consumption aggravates amyloid-β accumulation and cognitive impairments, and that modifiable lifestyle factors, such as obesity, can induce BACE1 post-modifications which may contribute to AD pathogenesis.

[1]  Chengfu Xu,et al.  Functions of amyloid precursor protein in metabolic diseases. , 2020, Metabolism: clinical and experimental.

[2]  P. Weinreb,et al.  Acute targeting of pre-amyloid seeds in transgenic mice reduces Alzheimer-like pathology later in life , 2020, Nature Neuroscience.

[3]  B. de Strooper,et al.  The β-Secretase BACE1 in Alzheimer’s Disease , 2020, Biological Psychiatry.

[4]  D. Holtzman,et al.  Alzheimer Disease: An Update on Pathobiology and Treatment Strategies , 2019, Cell.

[5]  Nektarios Tavernarakis,et al.  SUMOylation in Neurodegenerative Diseases , 2019, Gerontology.

[6]  Qianchun Deng,et al.  Melatonin alleviates cognition impairment by antagonizing brain insulin resistance in aged rats fed a high‐fat diet , 2019, Journal of pineal research.

[7]  S. Chirumbolo,et al.  Molecular Targets in Alzheimer’s Disease , 2019, Molecular Neurobiology.

[8]  J. Henley,et al.  Extranuclear SUMOylation in Neurons , 2018, Trends in Neurosciences.

[9]  Bin Zhang,et al.  BACE1 SUMOylation increases its stability and escalates the protease activity in Alzheimer’s disease , 2018, Proceedings of the National Academy of Sciences.

[10]  F. Laezza,et al.  Cognitive deficits associated with a high-fat diet and insulin resistance are potentiated by overexpression of ecto-nucleotide pyrophosphatase phosphodiesterase-1 , 2018, International Journal of Developmental Neuroscience.

[11]  P. Gleeson,et al.  GGA1 regulates signal-dependent sorting of BACE1 to recycling endosomes, which moderates Aβ production , 2018, Molecular biology of the cell.

[12]  Miao Sun,et al.  Par3 and aPKC regulate BACE1 endosome-to-TGN trafficking through PACS1 , 2017, Neurobiology of Aging.

[13]  Gyu Hwan Park,et al.  Effect of high-fat diet on cognitive impairment in triple-transgenic mice model of Alzheimer's disease. , 2017, Biochemical and biophysical research communications.

[14]  R. Nisticò,et al.  The Involvement of Post-Translational Modifications in Alzheimer's Disease. , 2017, Current Alzheimer research.

[15]  G. Rammes,et al.  Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibition Impairs Synaptic Plasticity via Seizure Protein 6 , 2016, Biological Psychiatry.

[16]  Yu Hasegawa,et al.  High‐Fat‐Diet Intake Enhances Cerebral Amyloid Angiopathy and Cognitive Impairment in a Mouse Model of Alzheimer's Disease, Independently of Metabolic Disorders , 2016, Journal of the American Heart Association.

[17]  Stéphane Martin,et al.  Sumoylation in Synaptic Function and Dysfunction , 2016, Front. Synaptic Neurosci..

[18]  D. Nicholson,et al.  Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer’s disease , 2016, Acta Neuropathologica.

[19]  Jeong Hee Kim,et al.  Enhancement of BACE1 Activity by p25/Cdk5-Mediated Phosphorylation in Alzheimer’s Disease , 2015, PloS one.

[20]  K. Ye,et al.  SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination , 2014, Proceedings of the National Academy of Sciences.

[21]  J. Henley,et al.  Neuronal SUMOylation: mechanisms, physiology, and roles in neuronal dysfunction. , 2014, Physiological reviews.

[22]  D. Nicholson,et al.  The Alzheimer’s β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques , 2013, Acta Neuropathologica.

[23]  L. Mei,et al.  VPS35 regulates developing mouse hippocampal neuronal morphogenesis by promoting retrograde trafficking of BACE1 , 2012, Biology Open.

[24]  C. Masters,et al.  sAPPα rescues deficits in amyloid precursor protein knockout mice following focal traumatic brain injury , 2012, Journal of neurochemistry.

[25]  C. Haass,et al.  Trafficking and proteolytic processing of APP. , 2012, Cold Spring Harbor perspectives in medicine.

[26]  B. Oh,et al.  DeSUMOylating isopeptidase: a second class of SUMO protease , 2012, EMBO reports.

[27]  L. Reijmers,et al.  Natural Amyloid-Beta Oligomers Acutely Impair the Formation of a Contextual Fear Memory in Mice , 2012, PloS one.

[28]  Patty C. Kandalepas,et al.  The β-secretase enzyme BACE1 as a therapeutic target for Alzheimer's disease , 2011, Alzheimer's Research & Therapy.

[29]  L. Fratiglioni,et al.  Midlife overweight and obesity increase late-life dementia risk , 2011, Neurology.

[30]  D. Selkoe,et al.  Soluble amyloid β-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration , 2011, Proceedings of the National Academy of Sciences.

[31]  J. Henley,et al.  Mechanisms, regulation and consequences of protein SUMOylation. , 2010, The Biochemical journal.

[32]  E. Barrett-Connor,et al.  Central obesity and increased risk of dementia more than three decades later , 2008, Neurology.

[33]  F. Melchior,et al.  Concepts in sumoylation: a decade on , 2007, Nature Reviews Molecular Cell Biology.

[34]  Kathryn Moynihan Ramsey,et al.  High-fat diet disrupts behavioral and molecular circadian rhythms in mice. , 2007, Cell metabolism.

[35]  R. Berry,et al.  β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Levels Become Elevated in Neurons around Amyloid Plaques: Implications for Alzheimer's Disease Pathogenesis , 2007, The Journal of Neuroscience.

[36]  S. Small,et al.  Sorting through the Cell Biology of Alzheimer's Disease: Intracellular Pathways to Pathogenesis , 2006, Neuron.

[37]  Wanpin Chang,et al.  GGA Proteins Mediate the Recycling Pathway of Memapsin 2 (BACE)* , 2005, Journal of Biological Chemistry.

[38]  B. Frier,et al.  The relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitations. , 2004, European journal of pharmacology.

[39]  Joanna L. Jankowsky,et al.  Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: evidence for augmentation of a 42-specific γ secretase , 2004 .

[40]  D. Holtzman,et al.  Aβ immunization and anti-Aβ antibodies: potential therapies for the prevention and treatment of Alzheimer’s disease , 2002 .

[41]  J. Buxbaum,et al.  The Carboxyl-Terminus of BACE Contains a Sorting Signal That Regulates BACE Trafficking but Not the Formation of Total Aβ , 2002, Molecular and Cellular Neuroscience.

[42]  J. Trill,et al.  Characterization of the Glycosylation Profiles of Alzheimer's β-Secretase Protein Asp-2 Expressed in a Variety of Cell Lines* , 2001, The Journal of Biological Chemistry.

[43]  G. Multhaup,et al.  Phosphorylation Regulates Intracellular Trafficking of β-Secretase* , 2001, The Journal of Biological Chemistry.

[44]  V. Katta,et al.  Characterization of Alzheimer's beta -secretase protein BACE. A pepsin family member with unusual properties. , 2000 .

[45]  E. Futai.  Advanced Yeast Models of Familial Alzheimer Disease Expressing FAD-Linked Presenilin to Screen Mutations and γ-Secretase Modulators. , 2019, Methods in molecular biology.

[46]  Hui Shen,et al.  The neuroprotection of liraglutide on Alzheimer-like learning and memory impairment by modulating the hyperphosphorylation of tau and neurofilament proteins and insulin signaling pathways in mice. , 2013, Journal of Alzheimer's disease : JAD.

[47]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[48]  R. Vassar.  BACE1: the beta-secretase enzyme in Alzheimer's disease. , 2004, Journal of molecular neuroscience : MN.